Key result
Treatment with potassium supplementation, methimazole, and propranolol normalized serum potassium levels to 4.7 mmol/L and restored motor function in a patient with thyrotoxic periodic paralysis.
Why the study?
Thyrotoxic periodic paralysis remains a diagnostic challenge, highlighting the need for early consideration of endocrine and metabolic causes of acute flaccid paralysis.
Case Report (n=1)
No
This case highlights the importance of considering thyrotoxic periodic paralysis in young patients presenting with acute flaccid paralysis and severe hypokalemia.
Answers are grounded in this paper and cite their sources.
Consider thyrotoxic periodic paralysis in hypokalemic paralysis; case extends recognized spectrum to include urinary retention.
Thyrotoxic periodic paralysis is a life-threatening complication characterized by acute paralysis of proximal muscles with severe hypokalemia in patients with a known or undiagnosed history of thyrotoxicosis. A 24-year-old man was brought to the emergency room with 1 month of progressively worsening lower-extremity weakness followed by urinary retention. He demonstrated severe motor weakness in proximal muscles with absent reflexes. Laboratory testing showed a dangerously low potassium of 1.3 mmol/L. Further testing to establish an etiology revealed a new diagnosis of thyrotoxicosis, and the patient was also started on the antithyroid medication methimazole and propranolol. Immediate oral and intravenous potassium supplementation was initiated to normalize the serum potassium levels to 4.7 mmol/L; that was followed by the gradual recovery of his motor function. This case report highlights the need for early consideration of endocrine and metabolic causes of acute flaccid paralysis.
No takes yet. Share an insight, caveat, or question.
Patti et al. (2022) conducted a case report in Thyrotoxic periodic paralysis (n=1). Potassium supplementation, methimazole, and propranolol was evaluated on Recovery of motor function and normalization of serum potassium. Treatment with potassium supplementation, methimazole, and propranolol normalized serum potassium levels to 4.7 mmol/L and restored motor function in a patient with thyrotoxic periodic paralysis.
Synapse has enriched 10 related papers. Consider them for comparative context: